Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Total Voting Rights

30 Dec 2014 07:00

RNS Number : 8604A
Fitbug Holdings PLC
30 December 2014
 



Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

30 December 2014

Fitbug Holdings plc ('Fitbug' or 'the Company')

Total Voting Rights

 

Further to the announcement of 9 December 2014, Fitbug Holdings Plc, the AIM quoted provider of online personal health and wellbeing services, is pleased to confirm that the 39,002,224 Placing Shares and 33,333,333 Loan Conversion Shares have now been admitted to trading on AIM, effective 30 December 2014.

 

Fergus Kee, Executive Chairman, said, "I would like to take this opportunity to welcome new shareholders to the Company and thank existing investors for their continued support. With the help of these funds and strong prospects, I believe that Fitbug is now entering a very exciting period as we start the new year."

 

Following Admission of the Placing Shares and Loan Conversion Shares, for the purposes of the FCA's Disclosure and Transparency Rules, the Company advises that the total number of shares in issue and total voting rights will be 240,850,530 Ordinary Shares of 1 pence each.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.

 

Upon Admission, the Placing Shares will represent 16.19 per cent. and the Loan Conversion Shares 13.84 per cent. of the enlarged share capital. The Placing Shares and Loan Conversion Shares will rank pari passu with the existing Ordinary Shares, including the right to all dividends and other distributions, paid or made after the date of issue.

 

Following the Admission of these shares to AIM, the directors below now hold the following shares in the Company:

 

Shareholder No. of Shares % of issued share capital

 

Fergus Kee 22,916,667 9.51%

David Turner* 12,515,000 5.20%

Allan Fisher** 10,890,000 4.52%

Paul Landau 8,788,894 3.65%

 

* Persons connected with David Turner have an interest in 6,280,000 ordinary shares representing 2.61 per cent. of the issued share capital of the Company

** Persons connected with Allan Fisher have an interest in 6,280,000 ordinary shares representing 2.61 per cent. of the issued share capital of the Company

 

**ENDS**

 

For further information visit www.kiqplan.com or www.fitbugholdings.com contact:

 

Paul Landau/Andrew Brummer

Fitbug Holdings Plc

020 7449 1000

Mark Percy/Catherine Leftley

Cantor Fitzgerald Europe

020 7894 7000

Claire Louise Noyce / William Lynne / Niall Pearson

Hybridan LLP, Broker and advisor to the placing

0203 713 4580/4582/4583

Elisabeth Cowell/Charlotte Heap

St Brides Media & Finance Ltd

020 7236 1177

 

 

 

Notes

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to the Fitbug app and fitbug.com to provide an understanding of each user's daily activity achievements, with mobile and web technology which provides users with personalised weekly activity and nutrition targets, feedback, advice and encouragement. Its "Kiqplan"TM digital health coaching platform is designed to make wearable technology relevant to new audiences and take the "so what?" out of activity tracking by providing structured action plans to help people get fitter, lighter and lead happier, healthier lives.

 

Key market sectors and distribution channels include retail, health insurance and rewards providers, workplace health programmes, fitness operators and consumers. Increasingly, Fitbug's platforms act as the driving force behind third party services such as white label sites, activity driven games and challenge microsites and rewards programmes. An important part of the Company's focus is on building strategic partnerships with organisations which can integrate Fitbug into their own service/product offerings or resell to their customer base. The Company has operations in the UK, Australia and Asia, with the United States remaining the primary market. For more information, visit www.fitbug.com and wwwkiqplan.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRPGGAWPUPCGAB
Date   Source Headline
5th Oct 20224:35 pmRNS£10m Placing/Subscription ABB & Rex Retail Offer
21st Sep 20224:40 pmRNSSecond Price Monitoring Extn
21st Sep 20224:36 pmRNSPrice Monitoring Extension
21st Sep 20222:05 pmRNSSecond Price Monitoring Extn
21st Sep 20222:00 pmRNSPrice Monitoring Extension
20th Sep 202211:21 amRNSRevised Market Forecasts
20th Sep 20227:03 amRNSBidstack Expands US Operation with CRO Hire
20th Sep 20227:00 amRNSStrategy for Accelerated Growth in the US
12th Sep 20224:41 pmRNSSecond Price Monitoring Extn
12th Sep 20224:35 pmRNSPrice Monitoring Extension
31st Aug 20223:50 pmRNSNew IAB Intrinsic In-Game Measurement Standards
17th Aug 20227:00 amRNSSports Interactive, exclusive multi-year renewal
8th Aug 20227:00 amRNSInterim Results - six months ended 30 June 2022
11th Jul 20227:00 amRNSAsia-Pacific enterprise software deal
7th Jul 20224:40 pmRNSSecond Price Monitoring Extn
7th Jul 20224:35 pmRNSPrice Monitoring Extension
7th Jul 20227:00 amRNSTrading Update
17th Jun 20227:00 amRNSAppointment of Chairman Designate
24th May 202211:03 amRNS2022 AGM Results
23rd May 20227:00 amRNSHolding in Company
12th May 20229:05 amRNSSecond Price Monitoring Extn
12th May 20229:00 amRNSPrice Monitoring Extension
5th May 20227:00 amRNSBidstack adds four games from Highbrow Interactive
28th Apr 20225:15 pmRNSAnnual Report & Accounts and Notice of AGM
28th Apr 20227:00 amRNSBidstack Expands Portfolio With New Partnership
27th Apr 20227:00 amRNSFinal Results
8th Apr 202211:05 amRNSSecond Price Monitoring Extn
8th Apr 202211:00 amRNSPrice Monitoring Extension
24th Mar 20224:41 pmRNSSecond Price Monitoring Extn
24th Mar 20224:35 pmRNSPrice Monitoring Extension
21st Mar 202211:05 amRNSSecond Price Monitoring Extn
21st Mar 202211:00 amRNSPrice Monitoring Extension
18th Mar 202211:05 amRNSSecond Price Monitoring Extn
18th Mar 202211:00 amRNSPrice Monitoring Extension
9th Mar 20229:00 amRNSPrice Monitoring Extension
9th Mar 20227:00 amRNSBidstack partners with GroupM’s Xaxis
3rd Mar 20228:00 amRNSBidstack partners farm simulation game Goodville
25th Feb 20224:40 pmRNSSecond Price Monitoring Extn
25th Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20227:00 amRNSBidstack adds 3 new titles from Game Tap Studios
8th Feb 20227:00 amRNSAppointment of CTO/CPO
24th Jan 20222:06 pmRNSSecond Price Monitoring Extn
24th Jan 20222:00 pmRNSPrice Monitoring Extension
19th Jan 20227:00 amRNSChange of Registered Office
10th Jan 20229:00 amRNSPrice Monitoring Extension
6th Jan 20224:41 pmRNSSecond Price Monitoring Extn
6th Jan 20224:36 pmRNSPrice Monitoring Extension
6th Jan 202211:06 amRNSSecond Price Monitoring Extn
6th Jan 202211:00 amRNSPrice Monitoring Extension
22nd Dec 20217:00 amRNSAdoption and Grant of LTIP Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.